Roth Capital reiterated coverage on Translate Bio with a new price target
$TBIO
Biotechnology: Laboratory Analytical Instruments
Industrials
Roth Capital reiterated coverage of Translate Bio with a rating of Buy and set a new price target of $45.00 from $28.00 previously